Charge-based binding of complement component C1q to the Alzheimer amyloid β-peptide

American Journal of Pathology

Volumn 150, Issue 5, 1997, Pages 1531-1536

  Webster, Scott ^a   Bonnell, Barry ^b,c   Rogers, Joseph ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; COMPLEMENT COMPONENT C1Q;

ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; COMPLEMENT FIXATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; COMPLEMENT C1Q; COMPLEMENT PATHWAY, CLASSICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; PROTEIN BINDING;

EID: 0030978135     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Joachim CL, Selkoe DJ: The seminal role of β-amyloid in the pathogenesis of Alzheimer disease. Alzheimer Dis Assoc Dis 1992, 6:7-34
2. Cotman CW, Pike CJ: β-amyloid and its contributions to neurodegeneration in Alzheimer disease. Alzheimer Disease. Edited by RD Terry, R Katzman, KL Bick. New York, Raven Press, 1994, pp 305-315
3. Davis JB, McMurray HF, Schubert D: The amyloid β-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes. Biochem Biophys Res Commun 1992, 189:1096-1100
4. Rogers J, Cooper NR, Webster S, Schultz J, McGeer PL, Styren SD, Civin WH, Brachova L, Bradt B, Ward P, Lieberburg I: Complement activation by β-amyloid in Alzheimer's disease. Proc Natl Acad Sci USA 1992, 89:10016-10020
5. Haga S, Ikeda K, Sato M, Ishii T: Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement C3 component by cultured microglial cells. Brain Res 1993, 601:88-94
6. Jiang H, Burdick D, Glabe CG, Cotman CW, Tenner AJ: β-amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J Immunol 1994, 152:5050-5059
7. Klegeris A, Walker DG, McGeer PL: Activation of macrophages by Alzheimer β-amyloid peptide. Biochem Biophys Res Commun 1994, 199:984-991
8. Mrak RE, Sheng JG, Griffin WS: Glial cytokines in Alzheimer's disease: review and pathogenic implications, Hum Pathol 1995, 26:816-23
9. Kuby J: Immunology. New York, WH Freeman and Co, 1994, pp 393-411
10. Eikelenboom P, Stam FC: Immunoglobulins and complement factors in senile plaques. Acta Neuropathol 1982, 57:239-242
11. Eikelenboom P, Stam FC: An immunohistochemical study on cerebral vascular and senile plaque amyloid in Alzheimer's dementia. Virchows Arch B Cell Pathol 1984, 47:17-25
12. Eikelenboom P, Hack CE, Rozemuller JM, Stam FC: Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch B Cell Pathol 1989, 56:259-262
13. Eikelenboom P, Rozemuller JM, Kraal G, Stam FC, McBride PA, Bruce ME, Fraser H: Cerebral amyloid plaques in Alzheimer's disease but not in scrapie-affected mice are closely associated with a local inflammatory process. Virchows Arch B Cell Pathol 1991, 60:329-336
14. Eikelenboom P, Zhan SS, Kamphorst W, van der Valk P, Rozemuller JM: Cellular and substrate adhesion molecules (integrins) and their ligands in cerebral amyloid plaques in Alzheimer's disease. Virchows Arch B Cell Pathol 1994, 424:421-427
15. McGeer PL, Akiyama H, Itagaki S, McGeer EG: Immune system response in Alzheimer's disease. Can J Neurol Sci 1989, 16:516-527
16. Akiyama H, McGeer PL: Brain microglia constitutively express β-2 integrins. J Neuroimmunol 1990, 30:81-93
17. Lue L-F, Rogers J: Full complement activation fails in diffuse plaques of the Alzheimer's disease cerebellum, Dementia 1992, 3:308-313
18. Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW: In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 1991, 563:311-314
19. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW: Neurodegeneration induced by β-amyloid peptides In vitro: the role of peptide assembly state. J Neurosci 1993, 13:1676-1687
20. Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW: Structure-activity analyses of β-amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity. J Neurochem 1995, 64:253-265
21. Mattson MP, Tomaselli KJ, Rydel RE: Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res 1993, 621:35-49
22. Lorenzo A, Yankner BA: β-amyloid neurotoxicity requires fibril formation and is inhibited by Congo Red. Proc Natl Acad Sci USA 1994, 91:12243-12247
23. Simmons LK, May PC, Tomaselli KJ, Rydel RE, Fuson KS, Brigham EF, Wright S, Lieberburg I, Becker GW, Brems DN, Li WY: Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Mol Pharmacol 1994, 45:373-379
24. Ueda K, Fukui Y, Kageyama H: Amyloid β protein-induced neuronal cell death: neurotoxic properties of aggregated amyloid β protein. Brain Res 1994, 639: 240-244
25. Webster S, O'Barr S, Rogers J: Enhanced aggregation and β structure of amyloid β peptide after co-incubation with C1q. J Neurosci Res 1994, 39:448-456
26. Webster S, Glabe C, Rogers J: Multivalent binding of complement protein C1q to the amyloid β-peptide (Aβ) promotes the nucleation phase of Aβ aggregation. Biochem Biophys Res Commun 1995, 217:869-875
27. Webster S, Rogers J: Relative efficacies of amyloid β peptide (Aβ) binding proteins in Aβ aggregation. J Neurosci Res 1996, 46:58-66
28. Roher AE, Lowenson JD, Clarke S, Wolkow C, Wang R, Cotter RJ, Reardon IM, Zurcher-Neely HA, Heinrikson RL, Ball MJ, Greenberg BD: Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem 1993, 268:3072-3083
29. Cooper NR: The classical complement pathway: activation and regulation of the first complement component. Adv Immunol 1985, 37:151-166
30. Halverson K, Fraser PE, Kirschner DA, Lansbury PT: Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic β-protein fragments. Biochemistry 1990, 29:2639-2644
31. Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K: Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease. J Mol Biol 1991, 218:149-163
32. Soreghan B, Kosmoski J, Glabe C: Surfactant properties of Alzheimer's Aβ peptides and the mechanism of amyloid aggregation. J Biol Chem 1994, 269:28551-28554
33. Rogers J, Lue L-F, Brachova L, Webster S, Schultz J: Inflammation as a response and a cause of Alzheimer's pathophysiology. Dementia 1995, 9:133-138
34. Rogers J, Webster S, Lue L-F, Brachova L, Civin WH, Emmerling M, Shivers B, Walker D, McGeer P: Inflammation and Alzheimer's pathogenesis. Neurobiol Aging 1996, 17:681-686